FAM24B inhibitors represent a specific class of chemical compounds meticulously designed to attenuate the activity of the FAM24B protein, a protein encoded by the FAM24B gene. These inhibitors are characterized by their ability to selectively bind to and neutralize the functional activity of FAM24B through various biochemical pathways. The inhibition of FAM24B is a targeted approach to modulate its role in cellular processes. Although the precise biological functions of FAM24B are not wholly delineated, inhibitors of this protein are designed based on the known interactions and pathways it is believed to participate in within the cell. For instance, if FAM24B is involved in cell signaling processes, its inhibitors could work by preventing the protein from interacting with key signaling molecules or by blocking its active site, thus preventing downstream signal transduction. In cases where FAM24B may play a role in the regulation of gene expression, inhibitors could hinder the protein's ability to bind to DNA or associated regulatory proteins, effectively silencing the gene networks it controls.
The design of FAM24B inhibitors takes into account the structural aspects of the protein, leveraging high-throughput screening and rational drug design to discover molecules that exhibit high affinity and specificity for FAM24B. The inhibitors might also function by disrupting the conformational stability of FAM24B, leading to a reduction in its functional form. For indirect inhibitors, the strategy includes identifying and targeting secondary pathways that are essential for the proper function of FAM24B. By doing so, these chemicals diminish the protein's activity by upstream or downstream effects. For instance, if FAM24B is part of a larger protein complex, disruption of this complex by an inhibitor could prevent FAM24B from performing its biological function. These compounds are also scrutinized for their ability to cross cell membranes and reach intracellular locations where FAM24B is active, ensuring that they can exert their inhibitory effects effectively within the cellular environment. The ultimate objective in the design and application of these inhibitors is to achieve a controlled and precise diminishment of FAM24B's activity without invoking broader systemic effects on the cell or organism.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and the complex inhibits mTOR (mechanistic target of rapamycin), which is a key protein in cell growth, proliferation, and survival. Downregulation of mTOR activity can reduce protein synthesis, potentially affecting the stability and function of FAM24B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K (phosphoinositide 3-kinases), which participate in the Akt/mTOR signaling pathway. Inhibition of this pathway can suppress the translation of various proteins, thereby potentially reducing FAM24B levels indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. By inhibiting PI3K, it impairs the PI3K/Akt/mTOR pathway vital for protein translation and cell survival, which may result in the downregulation of FAM24B expression as part of the global protein translation inhibition. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits the activation of Akt, a serine/threonine-specific protein kinase involved in cell survival and proliferation. By inhibiting Akt, FAM24B's stability and function, which may be dependent on Akt-mediated signaling, can be indirectly compromised. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which are upstream activators of ERK1/2 in the MAPK pathway. This pathway influences cell growth and differentiation, and its inhibition may affect cellular processes that contribute to the function or stability of FAM24B. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which can prevent the activation of the MAPK/ERK pathway. This may lead to decreased phosphorylation and activity of downstream proteins and indirectly reduce the functional activity of FAM24B if it is regulated by this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is involved in stress-induced apoptosis and inflammatory responses. By inhibiting JNK, it could potentially alter signaling pathways that contribute to the regulation and function of FAM24B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. Inhibition of p38 MAPK can lead to altered cell cycle progression and differentiation, which could indirectly affect the function or expression of FAM24B. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK, which plays a significant role in actin cytoskeleton organization. Disruption of ROCK activity could affect cell motility and survival, potentially impacting FAM24B's function if it is linked to these cellular processes. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. Aurora kinases are involved in mitotic progression, and their inhibition can lead to cell cycle arrest. This could indirectly affect the stability and function of FAM24B if it is regulated during the cell cycle. | ||||||